CardioWest temporary total artificial heart

Platis, Anthony; Larson, Douglas F.
September 2009
Perfusion;Sep2009, Vol. 24 Issue 5, p341
Academic Journal
Background: The CardioWest temporary total artificial heart (TAH-t) replaces both native ventricles of the heart and is more beneficial for a select group of patients than most other typical ventricular assist devices (VADs). This review will expand on the current literature and highlight the chronology of this device. The CardioWest TAH-t has been implanted in over 715 patients at 30 multiple institutional centers worldwide as a bridge-to-transplant (BTT) since 1993. The mechanical flow dynamics of the device are manufactured and designed differently from other traditional VADs, allowing increased outputs and normal filling pressures, allowing for sufficient organ and tissue perfusion and dramatic recoveries, allowing patients to return to an almost normal quality of life. Results: There was a 79% survival to transplant achievement in the protocol group who received the TAH-t versus a 46% in the control group (P < 0.001). Furthermore, there was a 70% survival rate at one year in the protocol group versus 31% in the control group (P < 0.001). The one- and five-year survival rates after transplantation were 69% and 34%, respectively, in the control group and 86% and 64%, respectively, in the protocol group. Conclusion: It is evident that the advancement of modern engineering and medicine has made way for a reliable and durable device that provides a promising future in the field of end-stage heart failure.


Related Articles

  • Developing and maintaining competency with circulatory assist devices: how to meet the challenge. Savage, Laura; Murphey, Jennifer; Joyce, Kenna // Progress in Transplantation;Jun2010, Vol. 20 Issue 2, p125 

    Heart failure is the only cardiovascular disease that is increasing in prevalence in developing countries. As a result, circulatory assist devices are being used more both as a bridge to heart transplantation and as destination therapy in patients with a failing heart. Nurses must become...

  • Ventricular assist device: saving the failing heart. Kurien, Sudha; Gallagher, Colleen // Progress in Transplantation;Jun2010, Vol. 20 Issue 2, p134 

    Background—Improving the survival and quality of life of patients with end-stage heart failure is the primary goal of using a ventricular assist device, generally known as mechanical circulatory support. Ventricular assist devices are a practical longterm surgical option for a select...

  • Ventricular assist devices for all? Krabatsch, Thomas; Potapov, Evgenij; Knosalla, Christoph; Hetzer, Roland // European Journal of Cardio-Thoracic Surgery;Dec2012, Vol. 42 Issue 6, p918 

    The authors reflect on the increase use of ventricular assist device (VAD) systems. They mention that over 10,000 of the HeartMate II VAD have been implemented since the introduction of the pump. They also explore whether the LVAD implantation should be declare as the primary therapy for...

  • heart, artificial. Peters, Michael // BMA A-Z Family Medical Encyclopedia;2004, p365 

    An encyclopedia entry for "artificial heart" is presented. It refers to an implantable mechanical device that takes over the action of the heart. It notes the function of an intra-aortic balloon pump, which is to increase the volume of blood entering the circulation. It also indicates the...

  • HEART SUPPORT SYSTEMS: FROM IDEA TO CLINICAL PRACTICE. Del Cañzo, Juan F. // Contributions of Macedonian Academy of Sciences & Arts;2008, Vol. 29 Issue 2, p61 

    This paper describes the development of a pneumatic ventricular assist device by our group from the firsts steps to the clinical assay. The device, called BCM, has an input compliant cannula that improves the filling of the device. Results of the clinical assay showed that the BCM device was...

  • Skipping The Beat. Bruning, Karla // Newsweek;10/30/2006, Vol. 148 Issue 18, pE2 

    The article reports on an artificial heart designed by Dr. O. H. Frazier. The heart pumps continuously and automatically adjusts to the body's needs like a normal heart. It's about the size of a thumb and is more durable than artificial hearts that produce a beat, such as AbioCor. It won't be...

  • Mechanical Cardiac-Support Devices – Dreams and Devilish Details. Jessup, Mariell // New England Journal of Medicine;11/15/2001, Vol. 345 Issue 20, p1490 

    The author reflects on the development of mechanical cardiac support devices specifically developed for patients with end-stage heart failure. According to the author, the development of this device was supported by the Artificial Heart Program of the National Heart, Lung and Blood Institute....

  • The TandemHeart as a Bridge to a Long-Term Axial-Flow Left Ventricular Assist Device. Gregoric, Igor D.; Jacob, Leon P.; La Francesca, Saverio; Bruckner, Brian A.; Cohn, William E.; Loyalka, Pranav; Kar, Biswajit; Frazier, O. H. // Texas Heart Institute Journal;2008, Vol. 35 Issue 2, p125 

    End-stage heart-failure patients in acute refractory cardiogenic shock with multi-organ dysfunction require aggressive medical therapy that includes inotropic support. Historically, the intra-aortic balloon pump was the last option for patients who were dying of acute cardiogenic shock....

  • Patient Logs One Year on Heart Pump. Zipes, Douglas // Medical Update;2004, Vol. 30 Issue 6, p4 

    Focuses on the implantation of HeartMate II, an alternative for heart transplant, on student Everardo Flores at the Texas Heart Institute in Houston, Texas. Benefits of the HeartMate II to patients with heart failure.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics